AVI BioPharma, Inc. (AVII)
A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.
Recs
brianpetro13
(39.67)
Submitted: 11/9/2009 3:37:44 PM :
Start Price:
$1.50
AVII Score:
-2.86
This stock is still performing strong even after today's quarterly report which was worse than expected. If that doesn't hold this stock down than I can't see anything in the immediate future which would reverse it's direction.
Recs
mjrruby
(< 20)
Submitted: 10/6/2009 4:04:11 PM :
Start Price:
$1.81
AVII Score:
-23.42
Just read Barons issue of Oct.5, 2009
Recs
EnigmaDude
(35.24)
Submitted: 10/5/2009 2:46:08 PM :
Start Price:
$1.95
AVII Score:
-30.30
Barrons write-up and today got approval for Junin virus drug.
Recs
rofgile
(88.29)
Submitted: 10/4/2009 12:33:49 PM :
Start Price:
$1.58
AVII Score:
-10.64
RNAI was a big technology for basic lab research in the 2000's. I was fairly doubtful, and still am, that this is a practical technology able to deliver interfering RNA to cells in a human body - it is difficult enough to deliver it to cells in a petri dish. They have a novel form of an RNAI inhibitor, it is not antisense RNA, which is what we all used. Instead it is a mimicing compound - that is why I am giving this an upthumb. I still think its crazy, but I don't think it is impossible. If it works, this company will be a leader in drug development.
Recs
kantv
(66.61)
Submitted: 9/17/2009 4:27:33 PM :
Start Price:
$1.84
AVII Score:
-22.91
This is one good pharma stock that will outperform in a few months
Recs
jpsdvp27
(< 20)
Submitted: 9/4/2009 2:42:52 PM :
Start Price:
$1.77
AVII Score:
-25.54
This will take off by mid sept.
Recs
Recs
Bojac3728
(93.54)
Submitted: 9/1/2009 9:54:05 AM :
Start Price:
$2.00
AVII Score:
-33.93
Good growthand earnings ahead.
Recs
jolaz
(< 20)
Submitted: 6/28/2009 3:14:17 AM :
Start Price:
$1.56
AVII Score:
-25.93
AVII is going to benefit from the swine flu hysteria. Only thing I don't like is 11 million warrants outstanding
Recs
Recs
StrategyGuru
(< 20)
Submitted: 10/22/2007 9:14:11 AM :
Start Price:
$2.82
AVII Score:
-25.34
This company recently changed it's management team and has made progress in obtaining govt. work. As with many companies, growing the federal allotment of funds provides stability & cashflow to accelerate growth. Look for federal funds to increase as well as new ventures.
Recs
audiowhore
(< 20)
Submitted: 5/8/2007 6:21:08 AM :
Start Price:
$3.04
AVII Score:
-28.90
just picked up a few shares monday for 3.05 a share on the basis the D.O.D. gave them a VERY SMALL chunk of change, I think just barely above $7mil to develope some homeland security vacines. The 52 wk high is more than double the current price. blah blah blah, it was an impulse buy.
Recs
nero2000
(< 20)
Submitted: 5/7/2007 8:49:25 AM :
Start Price:
$3.26
AVII Score:
-31.99
AVII is on the cutting edge of a huge wave of biopharma innovation that promises to transform modern medicine and healthcare.
Recs
gzulauf1
(< 20)
Submitted: 3/9/2007 5:45:20 PM :
Start Price:
$2.45
AVII Score:
-23.23
Risky, very promising technology, questionable management.
Recs
Recs
em5
(< 20)
Submitted: 2/11/2007 6:20:08 PM :
Start Price:
$2.93
AVII Score:
-30.97
Aiming towards some pretty big markets .At the moment though, still slogging it's way through ph I/II trials and anyone who follows Pharma or biotech knows that 90% of new drugs end up down the drain. I'm not letting that little fact deter me from this one though, they've got some good science going and a recent contract from the US gov shows confidence, don't laugh, in some areas in which they're working. Plus Duttons have them pretty high on their watch list which should mean something. And i like the price which isn't too hard to handle.
Recs
1tis
(94.07)
Submitted: 12/12/2006 8:07:48 AM :
Start Price:
$3.70
AVII Score:
-42.62
Its near its yearly lows. Has some good potential in the pipeline.
Recs
chgas12
(< 20)
Submitted: 11/29/2006 4:57:13 PM :
Start Price:
$3.64
AVII Score:
-42.72
Tremendous science with strong patent protection. Many opportunities for billion dollar drugs
Recs
ToogleBH
(72.58)
Submitted: 11/26/2006 12:27:03 AM :
Start Price:
$3.77
AVII Score:
-44.22
New treatments that have been used to cure VIRUSES in primates. Speculative, early stage.
Recs
bzshadow
(< 20)
Submitted: 11/22/2006 12:02:15 PM :
Start Price:
$3.76
AVII Score:
-43.75
speculative early stage biotech but leader in third generation antisense. ran up early last year but then sold off on early trial result for hep c. has potential to explode to upside and pretty good technology.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 28 1 2 Next »